• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Dr. Casella's #1 tip for managing dry eye


Optometry Times'® Chief Optometric Editor Ben Casella, OD, FAAO, gives his number 1 tip for managing DED.

Optometry Times®' Chief Optometric Editor Ben Casella, OD, FAAO, shares his top tip for managing dry eye disease (DED).

Key takeaways:

  • Dry eye disease is a disease
  • Patient history never ends
  • Stain more ocular surfaces
  • Express meibomian glands

This transcript has been lightly edited for clarity.

What is my number one tip for dry management for the eye doctor? I would say it's going to be the consummation of several tips, briefly.

I would say that dry eye disease is a disease. This is not just some ocular surface, artificial tear thing. Tears certainly have their place, but this is a disease. It has an ICD code, just like diabetes, just like glaucoma, just like cataracts. And we are poised to take on dry eye; optometry is poised for this.

Patient history never ends. If you're having a difficult refraction and a patient seeing, and then they blink and whoa, I can't see a darn thing, we need to pull the proctor back, we need to look at the ocular surface.

We need to stain more ocular surfaces than we do. We need to stain patients who may not be having any symptoms at all, or maybe having symptoms that they're not telling us about. The ocular surface will speak to you, we just have to look at it.

And maybe the most important tangible tip that I could give would be to express meibomian glands. And not just the ones on the lower lid, we need to express and see what's coming out of those glands. Is it a nice clear oil or is it toothpaste? And that's going to really drive our management, that's going to really tailor our therapy accordingly. Don't forget to express glands.

Related Videos
Adam Alexander, OD, chats with Optometry Times about his AOA e-poster presentation on Miebo
Megan Cavet, PhD
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Edmund Tsui, MD, details what insights swept-source anterior segment OCT images may give to determining eye inflammation
Michael Chaglasian, OD, details success of new OCT device at the ARVO 2024 meeting
Emily Chew, MD, outlines her lecture that landed her the Proctor Award at ARVO 2024
Deborah Ferrington details a session on mitochondrial maintenance and retinal health in patients with AMD at ARVO 2024
Andrew Pucker, OD, PhD
Dr. John Sheppard discusses results from trials testing the efficacy of eye drops to treat dry eye disease
© 2024 MJH Life Sciences

All rights reserved.